SplitNov 12, 2026, 04:19 PM
Silexion Therapeutics Completes 1-for-24 Reverse Stock Split
AI Summary
Silexion Therapeutics Corp has completed a 1-for-24 reverse share split, effective November 10, 2026. This action adjusted the terms of its outstanding warrants, reducing the number of shares issuable per warrant to 1/24th and increasing the exercise price to $372,600.00 per share. Fractional shares were rounded up, and the company's share structure was updated accordingly. The trading symbol remains SLXN.
Key Highlights
- Silexion Therapeutics Corp completed a 1-for-24 reverse share split, effective November 10, 2026.
- The number of ordinary shares issuable per warrant decreased to 1/24th of an ordinary share.
- The exercise price per warrant increased 24-fold to $372,600.00 per ordinary share.
- No fractional shares were issued; entitled shareholders received rounded-up whole shares.
- The company's authorized share capital remains $69,646,500, now consisting of 21,495,833 ordinary shares.
- The par value of ordinary shares increased from $0.135 to $3.24 per share.
Price Impact
More from SLXN